Genenta Science S.p.A. logo

Genenta Science S.p.A.

NASDAQ:GNTA

Overview | Financials
Company Name Genenta Science S.p.A.
Symbol GNTA
Currency USD
Price 4.135
Market Cap 75,327,121
Dividend Yield 0%
52-week-range 2.2 - 5.89
Industry Biotechnology
Sector Healthcare
CEO Mr. Pierluigi Paracchi
Website https://www.genenta.com

An error occurred while fetching data.

About Genenta Science S.p.A.

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with

Related Stocks

Pieris Pharmaceuticals, Inc. logo

Pieris Pharmaceuticals, Inc.

PIRS

17.04 USD

Graphite Bio, Inc. logo

Graphite Bio, Inc.

GRPH

3.18 USD

ImmunoPrecise Antibodies Ltd. logo

ImmunoPrecise Antibodies Ltd.

IPA

0.67 USD

Apyx Medical Corporation logo

Apyx Medical Corporation

APYX

1.3 USD

ORIC Pharmaceuticals, Inc. logo

ORIC Pharmaceuticals, Inc.

ORIC

9.65 USD

Gritstone bio, Inc. logo

Gritstone bio, Inc.

GRTS

0.467 USD

CorMedix Inc. logo

CorMedix Inc.

CRMD

5.76 USD

Financials

Numbers are in millions USD

Numbers are in millions USD